“IRBM is an important Italian biotech centre , which is giving a strategic contribution to the development of one of the vaccines against Covid-19 , a very important reality from the scientific point of view at international level.
Our Director of Peptide Chemistry, Elisabetta Bianchi, will be attending and speaking at the 1st International Oligonucleotide and Peptides Conference (IOPC 2019) in Milan from September 17-18.
The event will cover important and trending topics at the forefront of oligonucleotide and peptide innovation, in addition to regulatory and market trends. The conference also provides the opportunity to share insights and network with thought leaders in industry, academia and other associations.
On Wednesday 18 at 12:40pm, Elisabetta will be presenting a case study that highlights how appropriate screening for ADME properties and pseudo-allergic reactions is key to success in peptide drug discovery. This half-hour talk will take place in the Azalea room of the Ramada Plaza Milano.
Get in touch if you would like to arrange a meeting with us: https://www.irbm.com/contact-us/how-to-reach-us/